novo nordisk fda semaglutide and Hims & Hers settle lawsuit, allowing the telehealth platform to sell FDA-approved Wegovy and Ozempic GLP-1 drugs. Tap link in bio for full story FDA approves Ozempic® (semaglutide) as

Broader Public Education Advertising and Media Coverage The biggest driver is mass media advertising , especially from digital health companies like Hims and Ro , whove saturated platforms like TV, streaming, podcasts, and social media

Read the research article 5

The future of compounded semaglutide A similar recent FDA decision to remove the GLP-1 drug tirzepatide (Mounjaro/Zepbound) from the drug shortages list allows for up to 90 days from the calendar announcement to stop dispensing products

10.3390/molecules27248777 18 DongX.XuL

Distinguishing FDA-Approved Indications from Off-Label Prescribing Its key to know the difference between FDA-approved uses and off-label prescribing